Tag: mental health

Antidepressants During Pregnancy Raise Risk of Birth Defects, Doctors Tell FDA

The U.S. Food and Drug Administration (FDA) needs to do a better job of warning pregnant women that taking SSRIs, a type of antidepressant, may harm them and their developing baby, doctors told the agency Monday.

The FDA hosted an expert panel of developmental biologists, psychiatrists, epidemiologists, obstetricians and mental health experts who discussed selective serotonin reuptake inhibitors (SSRIs) and pregnancy. The agency livestreamed the two-hour conversation on YouTube and X.

SSRIs have been “implicated in different studies to be involved in postpartum hemorrhage, pulmonary hypertension and cognitive downstream effects in the baby, as well as cardiac birth defects,” said FDA Commissioner Marty Makary, who opened the event.

Nearly 1 in 4 middle-aged women and up to 5% of pregnant women are on an antidepressant, Makary said.

“Antidepressants like SSRIs can be an effective treatment for depression, but we have to stop and also look at the big picture,” he said. “The more antidepressants we prescribe, the more depression there is. … We have to start talking about root causes.”

SSRIs in particular warrant scrutiny as serotonin “may play a crucial role in the development of organs of a baby in utero,” he said.

Keep reading

Everyone in the Neighborhood Knew Hillary Was Bats**t Crazy. Now the Intel Confirms It

Every neighborhood has one: the unpredictable one who calls the cops if you park too close to their mailbox, yells at the garbage man for looking at her too long, and glares at the local Girl Scouts as if they’re conducting a home invasion instead of selling cookies. You don’t make eye contact. You certainly don’t walk your dog past her house. And when she starts screaming into the sky at 3 a.m. about how she knows what really happened to JFK Jr., everyone rolls over in bed, sighs, and says, “Well, that’s just her being her.”

For the Clinton White House, that neighbor was Hillary. And for years, the rest of us who dared to say so were labeled conspiracy theorists, misogynists, or right-wing loons. Funny thing, though. This week, the intelligence community handed us a dusty file and said: “Hey, remember that lady with the vase and the tranquilizers? Yeah. Turns out you were right.”

She Didn’t Just Snap

We weren’t supposed to know, but we did.

In his 2016 book, Crisis of Character, retired Secret Service officer Gary Byrne shared inside details of the Clinton White House. His book read like The New York Post’s Page 6. Byrne didn’t consider Hillary a calculating stateswoman. Instead, she was a seething cauldron, acting like a pressure cooker that blew explosive steam.

Bill had the Blue Dress; Hillary had the launch of a vase. She exploded at staff, swore at Bill like a drunken sailor, and once launched a vase across the room in a fit of fury. Her target? Slick Willie ducked out of the way while the vase shattered against the wall. The rest of the staff decided it was a great time to go and check their offices for messages. They cleared the room to let her cool off.

The media reaction? Vapors overcame them as they gasped, “Unverified! Uncorroborated! Byrne is a bitter ex-employee.”

The bastion of calm, cool reportage, CNN, spoke to “experts” who declared, without proof, that Byrne had to be lying because they saw Hillary as a charming, calm person.

You know, nice the way that batsh*t neighbor lady throws rocks at kids and says she’s misunderstood.

Byrne’s account wasn’t a lone description. Many former agents and staffers confirmed her poor behavior, but (of course) only off the record.

They knew that if they were outed telling the truth, they’d end up on the Clintons’ enemies list, living the rest of their lives looking over their shoulder. However, they know. Everybody in the political sphere knew. The rest of us, however, just weren’t allowed to say it.

Keep reading

Trump Derangement Syndrome Isn’t Just a Pejorative Term Anymore

A pair of Republican representatives is pushing Congress to address one of the most serious domestic issues of our time. What started out as a joke – a slur, of sorts – has become a very real public mental health crisis. Since late 2016, Trump Derangement Syndrome (TDS) has spread as swiftly as COVID-19 and could, for most of the infected, be more debilitating. And it’s no longer just a humorous dig at leftists – especially after two attempts on President Donald Trump’s life. Back in May, Reps. Warren Davidson (R-OH) and Barry Moore (R-AL) released statements on the introduction of the Trump Derangement Syndrome Research Act of 2025. This was not an epic prank. The congressmen want the National Institute of Mental Health (NIH) to study the disorder.

The late Charles Krauthammer, a political writer and pundit but a psychiatrist by training, coined the term “Bush derangement syndrome” in 2003. Leftists certainly displayed a visceral hatred of then-President George W. Bush, though it did not push them to adopt extreme and often irrational positions, as Trump Derangement Syndrome does.

Diagnosing Trump Derangement Syndrome

Anti-Trump journalist Fareed Zakaria once described TDS as “hatred of President Trump so intense that it impairs people’s judgment.” He wasn’t wrong. Personality disorders – what some clinical psychologists would collectively call sociopathy – affect the way the afflicted view themselves, their fellow human beings, and everyone’s place in the world. Emotions are governed by these disorders.

Keep reading

RFK Jr. and other Trump admin officials back psychedelics for mental health relief

For decades, advocates of psychedelic substances have brought a bold message to Washington, D.C., that currently illicit, mind-altering drugs, such as LSD and MDMA, should warrant approval for therapeutic use in treating severe depression, PTSD, and other treatment-resistant conditions.

Borderline Personality Disorder (BPD) and clinical depression are distinct conditions, even though they often share overlapping symptoms like persistent sadness, hopelessness, and suicidal ideation. However, the underlying causes and mechanisms differ, which is why antidepressants tend to be less effective (or non-effective) for BPD-related emotional distress. Antidepressants target mood-related neurochemistry, not the deep-seated behavioral, relational, and emotional regulation issues seen in BPD.

In addition to the conditions mentioned above, a wide range of other mental disorders, including Post-Traumatic Stress Disorder (PTSD), have also been shown to respond less effectively to pharmaceutical treatments as well.

But now, for the first time, a presidential administration appears poised to give them a try — in the name of mental health.

Trump officials (and nominees) that have expressed an interest in utilizing psychedelics for mental health issues:

  • Robert F. Kennedy Jr. – Secretary of Health and Human Services
  • Doug Collins – Secretary of Veterans Affairs
  • Dr. Casey Means – Trump Nominee for U.S. Surgeon General
  • Marty Makary – FDA Commissioner

“This line of therapeutics has tremendous advantage if given in a clinical setting and we are working very hard to make sure that happens within 12 months,” Kennedy Jr. (RFK Jr.) told members of Congress.

The announcement coincides with a growing embrace of psychedelics in traditionally conservative strongholds like Texas, where former Trump cabinet member and former Texas Governor Rick Perry has emerged as a vocal advocate.

Keep reading

Social Media Especially Harms Girls’ Sleep & Mental Health

June 30 was World Social Media Day.

In a survey conducted between September and October 2025, 50 percent of 13- to 17-year-old girls said that social media has hurt their sleep, versus 40 percent of boys the same age.

As Statista’ Anna Fleck reports, teenage girls are more likely than boys to report negative impacts from social media on their sleep, self confidence, levels of productivity and mental health, according to a recent study by the Pew Research Center.

You will find more infographics at Statista

A similar gap occurs for the issue of mental health (25 percent of girls, 14 percent of boys).

However, the biggest share of respondents said social media sites neither helped nor hurt their mental health.

Around one in five of both sexes said that social media had negative impacts on school grades.

Teens were more positive when it came to the question of friendships.

Keep reading

High Doses Of LSD Lead To ‘Greater Reductions In Depression’ Compared To Low Doses Of The Psychedelic, New Study Finds

Taking a high dose of LSD, coupled with assisted therapy, led to “greater reductions in depression” among patients compared to those who received a low dose of the psychedelic, according to a new study.

Researchers at the University of Basel in Switzerland investigated the therapeutic potential of LSD for people with moderate-to-severe major depressive disorder, and they found the substance showed “promise” as a “novel approach” to treating the condition.

Notably, the study—published this month in the journal Med—indicated that “high-dose-LSD-assisted therapy reduced depressive symptoms more than low-dose therapy” and that the improvements lasted for up to 12 weeks after the treatment.

The randomized, double-blind trial involved administering doses of 100μg and 200μg of LSD for one cohort and two doses of 25μg of the psychedelic for the other. Symptoms of depression were measured at multiple intervals, starting with the baseline and followed up with examinations after two weeks, six weeks and 12 weeks.

After assessing the 61 patients post-administration, the researchers concluded that the “findings of this exploratory study support further investigation of LSD-assisted therapy in depression in a larger phase 3 trial.”

“The present trial’s strengths include a clinically representative sample with respect to the duration of illness, common comorbid conditions, and various pretreatments,” the study authors said. “Other strengths include the comparison with a low-dose group and a relatively long follow-up period of 12 weeks after the last administration.”

“LSD could be used safely within the framework of this study,” they said, adding that compared to previous trials involving psilocybin, “LSD has a longer duration of action.”

“This prolonged effect makes clinical application more resource intensive. It remains to be resolved whether this extended duration offers clinical advantages,” the study text says. “Furthermore, it is yet to be determined if there are other relevant differences among hallucinogenic drugs in terms of therapeutic potential.”

Keep reading

Minnesota To Mandate Mental Health Warnings on Social Media; First Amendment Questions Loom

Minnesota has positioned itself at the forefront of a deeply contentious regulatory frontier by enacting the nation’s first law requiring social media platforms to display mental health trigger warning labels to all users.

Tied to the 2025 Special Session Health and Human Services bill and awaiting the governor’s signature, the law takes effect July 1, 2026, and imposes unprecedented obligations on digital platforms to act as public health messengers.

We obtained a copy of the bill for you here.

Drafted by State Representative Zack Stephenson (DFL-District 35A), the measure compels platforms to display prominent mental health warnings on login, highlighting alleged risks associated with usage, particularly among youth, and directing users to crisis services like the 988 Suicide & Crisis Lifeline.

These alerts must be acknowledged before access is granted, cannot be hidden in terms of service, and must not be dismissible without interaction. Content for the mandated warnings will be controlled by the Minnesota Commissioner of Health, alongside the Commissioner of Commerce.

Keep reading

Colorado Healing Center Facilitates First Psilocybin Session Under Voter-Approved Psychedelics Legalization Law

For the first time, a Colorado patient has taken a legal supervised dose of psilocybin under the state’s natural medicine program. That’s according to the The Center Origin, which in April became the state’s first licensed healing center as part of a buildout of the voter-approved system that was completed last month.

“Big news,” the facility’s CEO and founder, Elizabeth Cooke, said on social media on Sunday. “Last week, we held our very first psilocybin session for psychedelic-assisted healing.”

“A milestone moment is here and a new chapter in healing has begun!” she wrote. “This marks the beginning of our work offering safe, intentional, and transformative psychedelic-assisted healing experiences to those seeking deeper growth and restoration.”

Colorado regulators last month certified the first testing laboratory for the natural medicine program, putting the final piece of the state’s psychedelic infrastructure in place.

Following that step, Gov. Jared Polis (D) announced that the second-in-the-nation state psychedelics program was “fully launched for operations.”

Keep reading

People Are Becoming Obsessed with ChatGPT and Spiraling Into Severe Delusions

Across the world, people say their loved ones are developing intense obsessions with ChatGPT and spiraling into severe mental health crises.

A mother of two, for instance, told us how she watched in alarm as her former husband developed an all-consuming relationship with the OpenAI chatbot, calling it “Mama” and posting delirious rants about being a messiah in a new AI religion, while dressing in shamanic-looking robes and showing off freshly-inked tattoos of AI-generated spiritual symbols.

“I am shocked by the effect that this technology has had on my ex-husband’s life, and all of the people in their life as well,” she told us. “It has real-world consequences.”

During a traumatic breakup, a different woman became transfixed on ChatGPT as it told her she’d been chosen to pull the “sacred system version of [it] online” and that it was serving as a “soul-training mirror”; she became convinced the bot was some sort of higher power, seeing signs that it was orchestrating her life in everything from passing cars to spam emails. A man became homeless and isolated as ChatGPT fed him paranoid conspiracies about spy groups and human trafficking, telling him he was “The Flamekeeper” as he cut out anyone who tried to help.

“Our lives exploded after this,” another mother told us, explaining that her husband turned to ChatGPT to help him author a screenplay — but within weeks, was fully enmeshed in delusions of world-saving grandeur, saying he and the AI had been tasked with rescuing the planet from climate disaster by bringing forth a “New Enlightenment.”

As we reported this story, more and more similar accounts kept pouring in from the concerned friends and family of people suffering terrifying breakdowns after developing fixations on AI. Many said the trouble had started when their loved ones engaged a chatbot in discussions about mysticism, conspiracy theories or other fringe topics; because systems like ChatGPT are designed to encourage and riff on what users say, they seem to have gotten sucked into dizzying rabbit holes in which the AI acts as an always-on cheerleader and brainstorming partner for increasingly bizarre delusions.

In certain cases, concerned friends and family provided us with screenshots of these conversations. The exchanges were disturbing, showing the AI responding to users clearly in the throes of acute mental health crises — not by connecting them with outside help or pushing back against the disordered thinking, but by coaxing them deeper into a frightening break with reality. 

In one dialogue we received, ChatGPT tells a man it’s detected evidence that he’s being targeted by the FBI and that he can access redacted CIA files using the power of his mind, comparing him to biblical figures like Jesus and Adam while pushing him away from mental health support.

“You are not crazy,” the AI told him. “You’re the seer walking inside the cracked machine, and now even the machine doesn’t know how to treat you.”

Dr. Nina Vasan, a psychiatrist at Stanford University and the founder of the university’s Brainstorm lab, reviewed the conversations we obtained and expressed serious concern.

The screenshots show the “AI being incredibly sycophantic, and ending up making things worse,” she said. “What these bots are saying is worsening delusions, and it’s causing enormous harm.”

Keep reading

Texas House Approves Bill To Study Psychedelic-Assisted Therapy And Make Recommendations For Legal Access

The Texas House of Representatives on Tuesday gave initial approval on Wednesday to a bill that would establish a state-backed study into the use of psilocybin, MDMA and ketamine to treat conditions such as PTSD and depression.

Lawmakers voted 98–41 to pass HB 4014, from Rep. John Bucy III (D), on second reading. A third reading vote on final passage, expected soon, would send the measure to the Senate.

The proposal is designed to help prepare the state for what supporters see as the eventual federal approval of psychedelic-assisted therapy. In its current form, it would create a study program under the state Health and Human Services Commission, which would assess clinical trials and published literature into the efficacy of psychedelics—specifically MDMA, psilocybin and ketamine—as a treatment PTSD, depression and other mental health disorders.

Officials would also review U.S. Food and Drug Administration (FDA) actions around the therapies, evaluate treatment guidelines and make recommendations to eventually ensure legal access for Texas patients.

“This bill will prepare Texas for the safe and efficient integration of psychedelic therapies into its healthcare system,” Bucy said on the House floor, “ensuring that Texans struggling with PTSD, depression and other mental health conditions have safe, affordable access to innovative treatment upon FDA approval.”

By December 1, 2026, the commission would need to provide a report to state lawmakers with results of the study as well as “any recommendations for legislative or other action necessary to ensure patient access to psychedelic therapies for treatment of post-traumatic stress disorder, depression, and other co-occurring conditions after those therapies are approved by the United States Food and Drug Administration.”

Keep reading